Idenix Pharmaceuticals to Present at Three Upcoming Investor Conferences
30 August 2012 - 6:05AM
Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), announced today that
Idenix management will participate in a panel discussion at
Citigroup's 7th Annual Biotech Day on September 5, 2012 at 10:45
a.m. ET at the Mandarin Oriental, Boston, and present corporate
overviews at the Stifel Nicolaus Healthcare Conference on September
6, 2012 at 3:15 p.m. ET at the Four Seasons, Boston and the Morgan
Stanley Global Healthcare Conference on September 10, 2012 at 1:15
p.m. ET at the Grand Hyatt, New York City.
The live and archived webcasts of the company presentations can
be accessed under "Events & Presentations" in the Idenix
Investor Center at www.idenix.com. Please log in approximately 5-10
minutes before each event to ensure a timely connection. The
archived replay will be available on the Idenix website for two
weeks following the conferences.
About Idenix
Idenix Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts, is a biopharmaceutical company engaged in the
discovery and development of drugs for the treatment of human viral
diseases. Idenix's current focus is on the treatment of patients
with chronic hepatitis C infection. For further information about
Idenix, please refer to http://www.idenix.com.
CONTACT: Idenix Pharmaceuticals Contacts:
Kelly Barry (617) 995-9033 (media)
Daniella Beckman (617) 224-4471 (investors)
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More Idenix Pharmaceuticals News Articles